Hiroaki Nagano

1997–2025 年に発表

170
論文数
18,124
被引用数
80
h 指数
155
i10 指数

被引用数

Hiroaki Nagano の年別被引用数1992 年: 被引用 1 件1993 年: 被引用 1 件1998 年: 被引用 9 件1999 年: 被引用 10 件2000 年: 被引用 25 件2001 年: 被引用 30 件2002 年: 被引用 31 件2003 年: 被引用 34 件2004 年: 被引用 41 件2005 年: 被引用 44 件2006 年: 被引用 38 件2007 年: 被引用 56 件2008 年: 被引用 46 件2009 年: 被引用 52 件2010 年: 被引用 59 件2011 年: 被引用 109 件2012 年: 被引用 151 件2013 年: 被引用 143 件2014 年: 被引用 150 件2015 年: 被引用 144 件2016 年: 被引用 109 件2017 年: 被引用 123 件2018 年: 被引用 143 件2019 年: 被引用 648 件2020 年: 被引用 798 件2021 年: 被引用 832 件2022 年: 被引用 592 件2023 年: 被引用 435 件2024 年: 被引用 706 件2025 年: 被引用 327 件2026 年: 被引用 10 件1994〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 1,633 件、この内訳の 18.9%アメリカ合衆国: 引用元論文 1,593 件、この内訳の 18.5%日本: 引用元論文 903 件、この内訳の 10.5%イタリア: 引用元論文 432 件、この内訳の 5%ドイツ: 引用元論文 370 件、この内訳の 4.3%イギリス: 引用元論文 358 件、この内訳の 4.2%フランス: 引用元論文 310 件、この内訳の 3.6%韓国: 引用元論文 280 件、この内訳の 3.2%スペイン: 引用元論文 181 件、この内訳の 2.1%カナダ: 引用元論文 179 件、この内訳の 2.1%オーストラリア: 引用元論文 159 件、この内訳の 1.8%インド: 引用元論文 158 件、この内訳の 1.8%
0%18.9%その他 24%

分野

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology26.5%
  • Immunology and Microbiology5.1%
  • Engineering1%
  • Computer Science1%
  • Neuroscience0.8%
  • その他1.6%

トピック

  • Hepatocellular Carcinoma Treatment and Prognosis5.5%
  • Cancer Immunotherapy and Biomarkers5.1%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.1%
  • Pancreatic and Hepatic Oncology Research3.6%
  • MicroRNA in disease regulation2.8%
  • Liver Disease Diagnosis and Treatment2.6%
  • その他76.3%

共著者

全論文

検索で開く
  1. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bradly G. Wouters, Giuseppe Masucci, Emilia Andersson, Eva Závadová, Michal Vočka, Jiří Špaček, Luboš Petruželka, B Konopásek, Pavel Dundr, Helena Skálová, Kristýna Němejcová, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Mihaela Angelova, Angela Vasaturo, Pauline Maby, S. Church, Helen K. Angell, Lucie Lafontaine, Daniela Bruni, Carine El Sissy, Nacilla Haicheur, Amos Kirilovsky, Anne Berger, Christine Lagorce, Jeffrey P. Meyers, Christopher Paustian, Zipei Feng, Carmen Ballesteros‐Merino, Jeroen R. Dijkstra, Carlijn van de Water, Shannon van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragoş Viorel Scripcariu, Boryana Konstantinova Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Kyogo Itoh, Prabhudas S. Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M. Marincola, Paolo A. Ascierto, Daniel J. Sargent, Bernard A. Fox, Jérôme Galon - The Lancet 2018 被引用: 2,058

  2. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology Research 2023 被引用: 269

  3. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice

    著者: , , , , , , , , , , , , , , , , - Hepatology 2016 被引用: 370

  4. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takuji Okusaka, Yoshihiro Sakamoto, Yasushi Kojima, Ryota Higuchi, Naoki Sasahira, Keiji Sano, Toshio Nakagohri, Yu Sunakawa, Soichiro Morinaga, Yusuke Kumamoto, Kazuya Sugimori, Tatsuya Nomura, Kazuto Shibuya, Isamu Makino, Kentaro Yamazaki, Nobumasa Mizuno, Ken Kamata, Hiroshi Wada, Kunihito Gotoh, Mitsugu Sekimoto, Tetsuo Ajiki, Ikuo Nakamura, Ikuya Miki, Hiroaki Nagano, Koji Ohta, Takehiro Okabayashi, Masayuki Furukawa, Nao Fujimori - The Lancet 2023 被引用: 232

  5. Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401‐ MITSUBA)

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepato-Biliary-Pancreatic Sciences 2022 被引用: 237

  6. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takehito Otsubo, Shin Ishihara, Takeshi Takahara, Mitsuo Shimada, Michiaki Unno, M Imamura, Nobuhiro Ohkochi, Yoshiaki Murakami, Jiro Fujimoto, Shinichi Ikuta, Y Fujino, Minoru Uebayashi, Shuichi Ishiyama, Norihisa Takakura, Yusuke Kumamoto, Takehito Kato, Isaku Yoshioka, Shinji Üemoto, Katsuhiko Yanaga - British journal of surgery 2018 被引用: 395

  7. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Etsuro Hatano, Yutaka Sasaki, Keisuke Hino, Takashi Kumada, Kazuhide Yamamoto, Yasuharu Imai, Shouta Iwadou, Chikara Ogawa, Takuji Okusaka, Fumihiko Kanai, Kohei Akazawa, Kenichi Yoshimura, Philip Johnson, Yasuaki Arai - ˜The œLancet. Gastroenterology & hepatology 2018 被引用: 309

  8. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Masucci, Emilia Andersson, Eva Závadová, Michal Vočka, Jiří Špaček, Luboš Petruželka, B Konopásek, Pavel Dundr, Helena Skálová, Kristýna Němejcová, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Lucie Lafontaine, Daniela Bruni, Anastasia Lanzi, Carine El Sissy, Nacilla Haicheur, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros‐Merino, Jeroen R. Dijkstra, Carlijn van de Water, Shannon van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragoş Viorel Scripcariu, Boryana Konstantinova Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Kyogo Itoh, Prabhudas S. Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M. Marincola, Paolo A. Ascierto, Bernard A. Fox, Franck Pagès, Jérôme Galon - Journal of Clinical Oncology 2020 被引用: 227

  9. Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning

    著者: , , , , , , , , , , , , , , - Modern Pathology 2020 被引用: 109

  10. CD13 is a therapeutic target in human liver cancer stem cells

    著者: , , , , , , , , , , , , - Journal of Clinical Investigation 2010 被引用: 606

  11. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population

    著者: , , , , , , , , , , , , , , , - Journal of Gastroenterology 2017 被引用: 157

  12. Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture

    著者: , , , , , , , , , , , , , , - International Journal of Molecular Sciences 2018 被引用: 101

  13. Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model

    著者: , , , , , , , , , , , , , , , , , , , - Biomaterials 2020 被引用: 81

  14. Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023

    著者: , , , , , , , , , , , , , , , , , - Liver Cancer 2024 被引用: 47

  15. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

    著者: , , , , , , , , , , , , , , , , , , , , - Hepatology Research 2019 被引用: 533

  16. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer

    著者: , , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2019 被引用: 126

  17. Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs

    著者: , , , , , , , , , , , , , , , , , , - Cell stem cell 2011 被引用: 754

  18. Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Masucci, Emilia Andersson, Eva Závadová, Michal Vočka, Jiří Špaček, Luboš Petruželka, B Konopásek, Pavel Dundr, Helena Skálová, Kristýna Němejcová, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Lucie Lafontaine, Pauline Maby, Amine Majdi, Assia Hijazi, Carine El Sissy, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros‐Merino, Jeroen R. Dijkstra, Carlijn van de Water, Shannon van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragoş Viorel Scripcariu, Boryana Konstantinova Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Prabhudas S. Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M. Marincola, Paolo A. Ascierto, Bernard A. Fox, Franck Pagès, Jérôme Galon - Cancers 2023 被引用: 30

  19. Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Kashima, Mika Kamata‐Sakurai, Shumpei Ishikawa, Hiroyuki Aburatani, Takehisa Kitazawa, Tomoyuki Igawa - Cancer Immunology Research 2024 被引用: 24

  20. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

    著者: , , , , , , , , , , , , - Journal of Hepatology 2011 被引用: 360

  21. Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial–Mesenchymal Transition-like Phenomenon

    著者: , , , , , , , , , , , - Annals of Surgical Oncology 2011 被引用: 167

  22. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis

    著者: , , , , , , , , , , , , , , - Hepatology 2012 被引用: 136

  23. A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial)

    著者: , , , , , , , , , , , , , , , , - Liver Cancer 2023 被引用: 25

  24. Rapamycin Causes Upregulation of Autophagy and Impairs Islets Function Both In Vitro and In Vivo

    著者: , , , , , , , , , , , , - American Journal of Transplantation 2011 被引用: 112